SCHEMBL2270137

SCHEMBL2270137

O=C(Nc1cc(-c2ccccc2)ccc1C(=O)O)c1cccc(Br)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 2/20 0.70
ACLY P53396 4/20 0.64
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
MAPT P10636 2/20 0.62
TDP1 Q9NUW8 2/20 0.62
ABL1 P00519 1/20 0.62
TSHR P16473 1/20 0.62
RIN1 Q13671 1/20 0.62
SUCNR1 Q9BXA5 1/20 0.62
PKM P14618 2/20 0.57
SERPINE1 P05121 1/20 0.56
DHODH Q02127 2/20 0.56
HDAC2 Q92769 3/20 0.55
AKR1C2 P52895 2/20 0.55
AKR1C1 Q04828 2/20 0.55
AKR1C4 P17516 1/20 0.55
AKR1C3 P42330 1/20 0.55
HDAC1 Q13547 3/20 0.55
HDAC3 O15379 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2275720 0.90 SUCNR1 (0.73) GRIK1ACLYMEN1KMT2AMAPT
SCHEMBL2275453 0.87 ACLY (0.76) GRIK1ACLYMEN1KMT2AMAPT
SCHEMBL2272270 0.85 SUCNR1 (0.67) GRIK1ACLYMEN1KMT2AMAPT
SCHEMBL2270222 0.84 DHODH (0.77) GRIK1ACLYMEN1KMT2AMAPT
SCHEMBL2271703 0.84 ACLY (0.64) GRIK1ACLYMEN1KMT2AMAPT
SCHEMBL2274100 0.84 ACLY (0.64) ACLYMEN1KMT2AMAPTSUCNR1
SCHEMBL2272881 0.84 HDAC1 (0.74) GRIK1ACLYMEN1KMT2AMAPT
SCHEMBL2272416 0.84 ACLY (0.64) GRIK1ACLYMEN1KMT2AMAPT
SCHEMBL2274563 0.84 ACLY (0.81) GRIK1ACLYMEN1KMT2ASUCNR1
SCHEMBL12121805 0.84 ALDH1A1 (0.75) GRIK1ACLYMEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 GRIK1 2029/4885ACLY 653/4885MEN1 3105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.